Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies
PLOS Computational Biology · 2023
DOI: 10.1371/journal.pcbi.1010423 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Computational Biology, 2023. Verfasst von Carolin Zitzmann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioinformatics, University Medicine Greifswald, Greifswald, Germany. Hauptthemen laut MEDLINE: RNA Viruses, Hepatitis C. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, NIH HHS, Bundesministerium für Bildung und Forschung.
Abstract (Originalsprache)
Plus-strand RNA viruses are the largest group of viruses. Many are human pathogens that inflict a socio-economic burden. Interestingly, plus-strand RNA viruses share remarkable similarities in their replication. A hallmark of plus-strand RNA viruses is the remodeling of intracellular membranes to establish replication organelles (so-called “replication factories”), which provide a protected environment for the replicase complex, consisting of the viral genome and proteins necessary for viral RNA synthesis. In the current study, we investigate pan-viral similarities and virus-specific differences in the life cycle of this highly relevant group of viruses. We first measured the kinetics of viral RNA, viral protein, and infectious virus particle production of hepatitis C virus (HCV), dengue virus (DENV), and coxsackievirus B3 (CVB3) in the immuno-compromised Huh7 cell line and thus without perturbations by an intrinsic immune response. Based on these measurements, we developed a detailed mathematical model of the replication of HCV, DENV, and CVB3 and showed that only small virus-specific changes in the model were necessary to describe the in vitro dynamics of the different viruses. Our model correctly predicted virus-specific mechanisms such as host cell translation shut off and different kinetics of replication organelles. Further, our model suggests that the ability to suppress or shut down host cell mRNA translation may be a key factor for in vitro replication efficiency, which may determine acute self-limited or chronic infection. We further analyzed potential broad-spectrum antiviral treatment options in silico and found that targeting viral RNA translation, such as polyprotein cleavage and viral RNA synthesis, may be the most promising drug targets for all plus-strand RNA viruses. Moreover, we found that targeting only the formation of replicase complexes did not stop the in vitro viral replication early in infection, while inhibiting intracellular trafficking processes may even lead to amplified viral growth.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Bioinformatics, University Medicine Greifswald, Greifswald, Germany.
- Theoretical Biology and Biophysics, Los Alamos National Laboratory, Los Alamos, New Mexico, United States of America.
- Research Group "Dynamics of Early Viral Infection and the Innate Antiviral Response", Division Virus-Associated Carcinogenesis (F170), German Cancer Research Center (DKFZ), Heidelberg, Germany.
- Dept of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.
- Division of infectious Diseases and Immunology, Virology Section, Dept of Biomolecular Health Sciences, Utrecht University, Utrecht, The Netherlands.
- Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Christopher Dächert, Alan S Perelson, Lars Kaderali
Förderung
- NIAID NIH HHS
- NIH HHS
- Bundesministerium für Bildung und Forschung
- Deutsche Forschungsgemeinschaft
- US Department of Energy
- National Institute of Health
Zitieren
APA
Zitzmann, C., Dächert, C., Schmid, B., van der Schaar, H., van Hemert, M., Perelson, A. S., van Kuppeveld, F. J. M., Bartenschlager, R., Binder, M., & Kaderali, L. (2023). Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies. PLOS Computational Biology. https://doi.org/10.1371/journal.pcbi.1010423
Vancouver
Zitzmann C, Dächert C, Schmid B, van der Schaar H, van Hemert M, Perelson AS, et al. Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies. PLOS Computational Biology. 2023. doi:10.1371/journal.pcbi.1010423
BibTeX
@article{Zitzmann2023,
author = {Zitzmann, Carolin and Dächert, Christopher and Schmid, Bianca and van der Schaar, Hilde and van Hemert, Martijn and Perelson, Alan S and van Kuppeveld, Frank J M and Bartenschlager, Ralf and Binder, Marco and Kaderali, Lars},
title = {Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies},
journal = {PLOS Computational Biology},
year = {2023},
doi = {10.1371/journal.pcbi.1010423}
}
EUVIMED